1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics 2021 - Europe

Pathology Analysis & Statistics 2021 - Europe

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Delve Insight
1-30 of about 300 reports

Spinal Cord Injury - Pipeline Insight, 2021

  • $ 2000
  • September 2021
  • 80 pages

“Spinal Cord Injury - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in Spinal Cord Injury pipeline landscape. It covers the pipeline drug ...

  • World
  • Taiwan
  • Neurological Disorder
  • Industry analysis

Major Depressive Disorder - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 175 pages

‘Major Depressive Disorder (MDD)–Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Major Depressive Disorder (MDD), historical and forecasted epidemiology in the United ...

  • Spain
  • France
  • Depression
  • Industry analysis

Functional Dyspepsia - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 64 pages

‘Functional Dyspepsia – Epidemiology Forecast—2030’ report delivers an in-depth understanding of Functional Dyspepsia, historical and forecasted epidemiology in the United States, EU5 (Germany, ...

  • Spain
  • Germany
  • Digestive System Disorder
  • Industry analysis

ESR1 Mutated Metastatic Breast Cancer - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 80 pages

‘ESR1 Mutated Metastatic Breast Cancer - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the ESR1 Mutated Metastatic Breast Cancer, historical and forecasted epidemiology ...

  • United States
  • Spain
  • Breast Cancer
  • Industry analysis

Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology forecast- 2030

  • $ 4750
  • August 2021
  • 180 pages

‘Chronic Obstructive Pulmonary Disease (COPD)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Chronic Obstructive Pulmonary Disease (COPD), historical and forecasted ...

  • United States
  • Spain
  • Respiratory Disease
  • Industry analysis
  • Chronic Obstructive Pulmonary Disease Prevalence

Soft Tissue Sarcoma - Pipeline Insight, 2021

  • $ 3000
  • July 2021
  • 248 pages

“Soft Tissue Sarcoma - Pipeline Insight, 2021,” report provides comprehensive insights about 130+ companies and 130+ pipeline drugs in Soft Tissue Sarcoma pipeline landscape. It covers the pipeline ...

  • World
  • Europe
  • Cancer
  • Industry analysis

Frontotemporal dementia - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 60 pages

“Frontotemporal dementia - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Frontotemporal dementia pipeline landscape. It covers the pipeline ...

  • World
  • Europe
  • Neurological Disorder
  • Industry analysis

Hidradenitis Suppurativa - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 70 pages

“Hidradenitis Suppurativa - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Hidradenitis Suppurativa pipeline landscape. It covers the ...

  • World
  • Europe
  • Autoimmune Disease
  • Industry analysis
  • Drug Approval

Genital Herpes - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 60 pages

“Genital Herpes – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Genital Herpes pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Baden-Württemberg
  • Therapy
  • Infectious Disease
  • Industry analysis

Genital herpes - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 60 pages

“Genital herpes - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Genital herpes pipeline landscape. It covers the pipeline drug profiles, ...

  • Baden-Württemberg
  • World
  • Therapy
  • Infectious Disease
  • Industry analysis

Chronic Hepatitis B Virus Infection - Pipeline Insight, 2021

  • $ 2500
  • July 2021
  • 60 pages

“Chronic Hepatitis B Virus Infection - Pipeline Insight, 2021,” report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in Chronic Hepatitis B Virus Infection pipeline landscape. ...

  • World
  • United Kingdom
  • Hepatitis
  • Industry analysis

Gastric Cancer - Pipeline Insight, 2021

  • $ 3000
  • July 2021
  • 60 pages

“Gastric Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Russia
  • Gastric Cancer
  • Industry analysis

Acute Ischemic Stroke - Pipeline Insight, 2021

  • $ 2000
  • May 2021
  • 60 pages

“Acute Ischemic Stroke – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Acute Ischemic Stroke pipeline landscape. It covers the pipeline ...

  • United Kingdom
  • United States
  • Stroke
  • Industry analysis

Glaucoma  - Epidemiology Forecast to 2030

  • $ 3750
  • May 2021
  • 156 pages

‘Glaucoma—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Glaucoma , historical and forecasted epidemiology as well as the Glaucoma trends in the United States, EU5 ...

  • Japan
  • Spain
  • Ophthalmology
  • Eye Disease
  • Industry analysis

Sepsis - Epidemiology Forecast to 2030

  • $ 3750
  • May 2021
  • 108 pages

‘Sepsis—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Sepsis , historical and forecasted epidemiology as well as the Sepsis trends in the United States, EU5 (Germany, ...

  • United States
  • Spain
  • Blood Disease
  • Industry analysis

Heart Failure - Epidemiology forecast- 2030

  • $ 3750
  • May 2021
  • 80 pages

‘Heart Failure (HF)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the HF, historical and forecasted epidemiology as well as the HF trends in the United States, EU5 (Germany, ...

  • United States
  • Spain
  • Heart Failure
  • Epidemiology
  • Industry analysis

Microscopic Polyangiitis - Epidemiology Forecast to 2030

  • $ 3750
  • May 2021
  • 80 pages

‘Microscopic polyangiitis (MPA) —Epidemiology Forecast–2030’ report delivers an in-depth understanding of the MPA, historical and forecasted epidemiology as well as the MPA epidemiology trends ...

  • Japan
  • Germany
  • Epidemiology
  • Autoimmune Disease
  • Industry analysis
  • Population Size

Wet Age-Related Macular Degeneration (Wet-AMD) - Pipeline Insight, 2021

  • $ 2500
  • May 2021
  • 190 pages

“Wet Age-Related Macular Degeneration (Wet-AMD) - Pipeline Insight, 2021,” report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Wet Age-Related Macular Degeneration ...

  • Europe
  • Australia
  • Eye Disease
  • Ophthalmology
  • Industry analysis

T cell lymphoma - Pipeline Insight, 2021

  • $ 2500
  • May 2021
  • 200 pages

“T cell lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in T cell lymphoma pipeline landscape. It covers the pipeline drug profiles, ...

  • United States
  • Europe
  • Lymphoma
  • Industry analysis

Exocrine Pancreatic Insufficiency (EPI) - Epidemiology Forecast–2030

  • $ 3750
  • April 2021
  • 90 pages

Overview ‘Exocrine Pancreatic Insufficiency (EPI) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Exocrine Pancreatic Insufficiency ...

  • Japan
  • Spain
  • Digestive System Disorder
  • Industry analysis

Diabetic retinopathy - Epidemiology Forecast to 2030

  • $ 3750
  • April 2021
  • 90 pages

‘Diabetic Retinopathy (DR) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Diabetic Retinopathy, historical and forecasted epidemiology in the United States, EU5 ...

  • United States
  • Germany
  • Type 2 Diabetes
  • Industry analysis
  • Diabetes Prevalence

Beta thalassemia - Pipeline Insight, 2021

  • $ 2000
  • March 2021
  • 60 pages

“Beta thalassemia - Pipeline Insight, 2021,” report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in Beta thalassemia pipeline landscape. It covers the pipeline drug profiles, ...

  • United States
  • World
  • Blood Disease
  • Industry analysis

Glioblastoma multiforme (GBM) - Epidemiology Forecast to 2030

  • $ 3750
  • February 2021
  • 171 pages

‘Glioblastoma Multiforme (GBM) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Glioblastoma Multiforme (GBM) epidemiology in the ...

  • Spain
  • France
  • Brain Cancer
  • Industry analysis

LY3454738- Emerging Insight and Market Forecast – 2030

  • $ 3250
  • February 2021
  • 35 pages

“LY3454738- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Chronic Spontaneous Urticaria in 7 Major Markets. A detailed ...

  • Japan
  • Spain
  • Research And Development
  • Dermatological Condition
  • Industry analysis
  • Health Expenditure

Aliqopa - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Aliqopa - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Aliqopa ...

  • Europe
  • Japan
  • Lymphoma
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Acalabrutinib- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“ACALABRUTINIB - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

BI 764524 - Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“BI 764524 - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diabetic Retinopathy in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Type 2 Diabetes
  • Research And Development
  • Industry analysis
  • Health Expenditure

ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diffuse large B-cell lymphoma (DLBCL) in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

Blinatumomab- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“BLINATUMOMAB - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B-cell lymphoma (DLBCL) in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Monoclonal Antibody
  • Industry analysis
  • Health Expenditure

DB-102- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“DB-102- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed ...

  • Europe
  • World
  • Lymphoma
  • Research And Development
  • Industry analysis
  • Health Expenditure

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on